Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen.

Delaugerre, Constance

Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. [electronic resource] - AIDS (London, England) Sep 2010 - 2391-5 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1473-5571

10.1097/QAD.0b013e32833d214c doi


Antiretroviral Therapy, Highly Active
DNA, Circular--drug effects
DNA, Viral--drug effects
Female
HIV Infections--drug therapy
HIV Long Terminal Repeat--drug effects
HIV-1--drug effects
Humans
Male
Pyrrolidinones--administration & dosage
Raltegravir Potassium
Sequence Analysis, DNA
Viral Load
Viremia